This project will examine the intracellular transport of two glycoproteins, immunoglobulins (Ig) and MHC class I antigens, in murine B lymphocytes. Proper intracellular transport of these proteins to the plasma membrane is cricial for the functioning of B lymphocytes as Ig secretors and as antigen presenters. Two stages of transport are of special interest: 1. The transition between the Endoplasmic Reticulum (ER) and the Golgi complex. 2. The transition between the Golgi complex and the cell surface. Our main question about the ER-Golgi transition is identifying those structural features of IG lambda chains which are crucial for executing this rate-limiting step of transport. Such features may in fact serve as transport signals, for example by mediating interactions of lambda with other cellular proteins. To identify and map such structural features, we shall construct lambda transport mutants and ask that they satisfy two requirements: that they fail to exit the ER and that they fold properly. Such mutants can reasonably be interpreted as defective in transport signals. These mutants will then be used to examine the role of resident ER proteins, like Binding Protein, in retaining non-secreted Ig in the ER. Understanding the transition between the Golgi complex and the cell surface is important with respect to Beta cell function in antigen presentation, since this is a stage where endocytosed ligands and receptors mix with the exocytic traffic. We observed that the protonophore CCCP perturbs transport through this stage, in a compartment distal to the Golgi stack, which we think is the trans-Golgi reticulum. We propose to characterize this compartment further, by immuno-electron microscopy and histochemistry. Moreover, we propose to isolate the trans-Golgi reticulum and study its biochemical properties. Finally, the transport of MHC class I antigens between the Golgi complex and the cell surface will be studied, by examining the phosphorylation of these molecules and the relation between phosphorylation and the traffic to and from the cell surface.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030178-03
Application #
3145289
Study Section
Immunobiology Study Section (IMB)
Project Start
1990-04-01
Project End
1993-08-31
Budget Start
1992-04-01
Budget End
1993-08-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Ostrovsky, Olga; Eletto, Davide; Makarewich, Catherine et al. (2010) Glucose regulated protein 94 is required for muscle differentiation through its control of the autocrine production of insulin-like growth factors. Biochim Biophys Acta 1803:333-41
Biswas, Chhanda; Ostrovsky, Olga; Makarewich, Catherine A et al. (2007) The peptide-binding activity of GRP94 is regulated by calcium. Biochem J 405:233-41
Elkabetz, Yechiel; Argon, Yair; Bar-Nun, Shoshana (2005) Cysteines in CH1 underlie retention of unassembled Ig heavy chains. J Biol Chem 280:14402-12
Gidalevitz, Tali; Biswas, Chhanda; Ding, Hua et al. (2004) Identification of the N-terminal peptide binding site of glucose-regulated protein 94. J Biol Chem 279:16543-52
Goyard, Sophie; Segawa, Hiroaki; Gordon, Jennifer et al. (2003) An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol Biochem Parasitol 130:31-42
Davis, D P; Gallo, G; Vogen, S M et al. (2001) Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. J Mol Biol 313:1021-34
Dul, J L; Davis, D P; Williamson, E K et al. (2001) Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains. J Cell Biol 152:705-16
Stevens, F J; Argon, Y (1999) Pathogenic light chains and the B-cell repertoire. Immunol Today 20:451-7
Stevens, F J; Argon, Y (1999) Protein folding in the ER. Semin Cell Dev Biol 10:443-54
Davis, D P; Khurana, R; Meredith, S et al. (1999) Mapping the major interaction between binding protein and Ig light chains to sites within the variable domain. J Immunol 163:3842-50

Showing the most recent 10 out of 14 publications